A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
Applying to Robert H. Lurie Comprehensive Cancer Center of Northwestern University · Chicago, Illinois
Answer a few short questions to share with the research team.